Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclins and cell cycle checkpoints.

D G Johnson1, C L Walker

  • 1M.D. Anderson Cancer Center, Smithville, Texas 78957, USA.

Annual Review of Pharmacology and Toxicology
|May 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes.

Oncogene·2017
Same author

Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL.

Oncogene·2017
Same author

Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.

Current molecular medicine·2016
Same author

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.

Oncogene·2015
Same author

High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.

Oncogene·2015
Same author

Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis.

Oncogene·2014
Same journal

Navigating the Computational Landscape for Drug Repurposing.

Annual review of pharmacology and toxicology·2026
Same journal

Microplastics and Atherosclerosis: Mechanisms.

Annual review of pharmacology and toxicology·2026
Same journal

Treating Pregnant and Lactating Women: Insights from Clinical Pharmacology.

Annual review of pharmacology and toxicology·2026
Same journal

<i>Caenorhabditis elegans</i> as a Model System for Environmental Mitotoxicants.

Annual review of pharmacology and toxicology·2025
Same journal

Introduction to the Theme "New Approaches, Technology, and Techniques That Advance Pharmacology and Toxicology".

Annual review of pharmacology and toxicology·2025
Same journal

A Mechanistic Framework for Repurposing FDA-Approved Drugs to Combat Antimicrobial Resistance: The Case of <i>Staphylococcus aureus</i>.

Annual review of pharmacology and toxicology·2025
See all related articles

The cell cycle is controlled by cyclins and cyclin-dependent kinases, with inhibitors like p21 and p16 crucial for preventing cancer. Therapeutic drugs target these cell cycle regulators to treat cancer by inducing cell death.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Pharmacology

Background:

  • The eukaryotic cell cycle is governed by cyclins and cyclin-dependent kinases.
  • Cell cycle inhibitors (e.g., p21, p16) are vital for checkpoint control and signal coordination.
  • Dysregulation of cell cycle genes is implicated in cancer development.

Purpose of the Study:

  • To explore the regulatory mechanisms of the cell cycle.
  • To understand the role of cell cycle proteins in cancer.
  • To review therapeutic strategies targeting cell cycle regulation in cancer treatment.

Main Methods:

  • Review of existing literature on cell cycle regulation.
  • Analysis of the role of cyclins, cyclin-dependent kinases, and inhibitors.
  • Examination of therapeutic agents targeting cell cycle checkpoints.

Related Experiment Videos

Main Results:

  • Cyclins and cyclin-dependent kinases drive cell cycle progression.
  • Inhibitors like p21 and p16 act as critical checkpoints.
  • Cancer often involves alterations in cell cycle regulatory genes.

Conclusions:

  • Understanding cell cycle regulation is key to cancer research and treatment.
  • Therapeutic agents exploit cell cycle disruptions to induce cancer cell apoptosis.
  • Targeted drugs like UCN-01 show promise in inhibiting cell cycle proteins.